Medicine plus mobile phone support to help people with HIV in India quit tobacco
Varenicline and mobile behavioral assistance for tobacco cessation in HIV care in India
This offers the quit-smoking pill varenicline together with a mobile phone behavioral program to help adults living with HIV in India stop using tobacco.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11166586 on NIH RePORTER |
What this research studies
If you live with HIV and use tobacco, this program combines the medication varenicline with a mobile version of the Positively Smoke Free behavioral support program and extra help to take your medicine. People are recruited from HIV clinics in Chennai where most patients have mobile phones. The mobile program sends counseling content and reminders while clinic staff provide adherence support for the medication. Quit rates and tobacco use will be tracked over time to see how well the combined approach works.
Who could benefit from this research
Good fit: Adults (21+) living with HIV who currently smoke or use tobacco, receive care at participating HIV clinics in India, and can use a mobile phone are ideal candidates.
Not a fit: People who do not use tobacco, cannot take varenicline for medical reasons, or lack access to a mobile phone or clinic follow-up may not benefit from this program.
Why it matters
Potential benefit: If successful, this approach could help more people with HIV in India quit tobacco and reduce tobacco-related health problems.
How similar studies have performed: In higher-income countries, the Positively Smoke Free program and varenicline have helped people with HIV quit, but combining them and delivering the behavioral support by mobile phone in India is relatively new.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Kruse, Gina Rae — University of Colorado Denver
- Study coordinator: Kruse, Gina Rae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.